Mankind Pharma Ltd (MANKIND) — Corporate Action | 1 September 2026
Mankind Pharma allotted 49,112 equity shares under its 2022 Employee Stock Option Plan on September 1, 2026, increasing paid-up capital from 41,29,95,978 to 41,30,45,090 shares at ₹1 face value. The shares carry a ₹860 exercise price and ₹859 premium, and rank pari-passu with existing shares.
About Mankind Pharma Ltd (MANKIND)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when MANKIND files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track MANKIND — Free💡 Ask AI about this filing
📊 More MANKIND filings
- 🔴 Announcement — 31 August 2026 Mankind Pharma announced it has completed the sale of its entire 100% stake in Broadway Hospitality ...
- 🟡 Board Meeting — 30 August 2026 Mankind Pharma announced that Independent Director Bharat Anand completed his second term effective ...
- 🟡 Board Meeting — 26 August 2026 Mankind Pharma announced that its board approved the voluntary liquidation of its 96%-owned subsidia...
- 🟡 Board Meeting — 26 August 2026 Mankind Pharma announced the board approved voluntary liquidation of its 96% owned subsidiary Bharat...
- Announcement — 22 August 2026 Mankind Pharma announced an independent ESG rating of 64 from CRISIL ESG Ratings, up from 57, placin...
🔥 Also filed on 1 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when MANKIND files new disclosures
Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MANKIND — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd